Both in Pharmaceuticals
Abbott Laboratories vs Bristol-Myers Squibb
Over the past year ABT returned −14.1% and BMY returned +35.6%; their daily moves had a correlation of 0.22.
ABT −14.1% BMY +35.6%Growth of $1, one year, split-adjusted
| Metric | ABT | BMY |
|---|---|---|
| Price | $106.20 | $62.48 |
| Market cap | $183.77B | $127.71B |
| Today | +1.56% | +1.78% |
| 1 month | +9.8% | +1.7% |
| 6 months | +18.7% | +7.3% |
| Year to date | −15.2% | +15.8% |
| 1 year | −14.7% | +46.7% |
| Revenue growth (YoY) | +13.0% | +5.7% |
| Gross margin | 57.7% | 71.3% |
| Net margin | 7.4% | 25.6% |
| P/E (TTM) | 33.9× | 13.8× |
| Price / sales | 3.9× | 2.6× |
| Net cash | -$27.00B | -$32.05B |
| Dividend yield | 2.37% | 4.03% |
| Volatility (60d) | 21.3% | 27.3% |
| Short % of float | 1.0% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).